The estimated Net Worth of Matthew Bennett Arnold is at least 25.8 百万$ dollars as of 14 January 2019. Mr. Arnold owns over 5,000 units of Solid Biosciences Inc stock worth over 25,363,335$ and over the last 6 years he sold SLDB stock worth over 310,400$. In addition, he makes 82,465$ as Independent Director at Solid Biosciences Inc.
Matthew has made over 2 trades of the Solid Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of SLDB stock worth 160,000$ on 14 January 2019.
The largest trade he's ever made was selling 5,000 units of Solid Biosciences Inc stock on 14 January 2019 worth over 160,000$. On average, Matthew trades about 1,111 units every 1 days since 2018. As of 14 January 2019 he still owns at least 3,386,293 units of Solid Biosciences Inc stock.
You can see the complete history of Mr. Arnold stock trades at the bottom of the page.
Matthew Arnold is an Independent Director of the Company. He is a founding member of Solid and has served as a member of our board of directors since our inception in 2013. A former energy executive, since 2009, Mr. Arnold has been actively working with startup businesses in the United Kingdom and Europe, primarily in the technology and clean tech sectors. He holds an M.S. from the University of Virginia and a B.A. from Duke University. Mr. Arnold is qualified to serve on our board of directors because of his extensive management and board experience with startup companies and his background in finance.
As the Independent Director of Solid Biosciences Inc, the total compensation of Matthew Arnold at Solid Biosciences Inc is 82,465$. There are 10 executives at Solid Biosciences Inc getting paid more, with Carl Morris having the highest compensation of 4,052,210$.
Matthew Arnold is 50, he's been the Independent Director of Solid Biosciences Inc since . There are 10 older and 8 younger executives at Solid Biosciences Inc. The oldest executive at Solid Biosciences Inc is Stephen J. DiPalma M.B.A., 62, who is the Treasurer & Principal Accounting Officer.
Matthew's mailing address filed with the SEC is 5th, 141 Portland St, Cambridge, MA 02139, USA.
Over the last 7 years, insiders at Solid Biosciences Inc have traded over 9,620,465$ worth of Solid Biosciences Inc stock and bought 13,973,934 units worth 97,227,521$ . The most active insiders traders include Advisors Llcperceptive Life...、Capital Management, L.P.Ra ...、Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of 1,822,871$. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth 24,380$.
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Solid Biosciences Inc executives and other stock owners filed with the SEC include: